Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "injectables"

111 News Found

Evonik expands production of plant-derived cholesterol in Germany
News | March 06, 2022

Evonik expands production of plant-derived cholesterol in Germany

The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol


Fitch revises outlook on Jubilant Pharma to negative; affirms at 'BB'
News | February 19, 2022

Fitch revises outlook on Jubilant Pharma to negative; affirms at 'BB'

Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).


Novo Nordisk India launches world’s first and only GLP-1 RA, oral semaglutide
Drug Approval | January 20, 2022

Novo Nordisk India launches world’s first and only GLP-1 RA, oral semaglutide

Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach


Outlook for the Indian Pharma Industry remains stable for this year
Opinion | January 13, 2022

Outlook for the Indian Pharma Industry remains stable for this year

The stability is led by healthy demand in the domestic and emerging markets


Margins under pressure; domestic market growth to slow down: Nirmal Bang
News | January 06, 2022

Margins under pressure; domestic market growth to slow down: Nirmal Bang

A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies


Domestic and emerging markets will drive pharma growth: ICRA
News | January 04, 2022

Domestic and emerging markets will drive pharma growth: ICRA

Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer
News | November 24, 2021

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer

For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore


Zydus Cadila receives approval for glycopyrrolate injection
Drug Approval | November 10, 2021

Zydus Cadila receives approval for glycopyrrolate injection

Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated


Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore
News | November 09, 2021

Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore

The company has operations in North America, Asia, and Europe,